NCT03761914 2024-11-19
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Sellas Life Sciences Group
Phase 1/2 Completed
Sellas Life Sciences Group
Sellas Life Sciences Group
Barbara Ann Karmanos Cancer Institute
National Institutes of Health Clinical Center (CC)
University of Washington
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)